Stem-Cell Transplantation
CD133-based stem-cell selection feasible with alternative donors
Published in Blood Weekly, February 5th, 2004
"Positive selected hematopoietic stem cells are increasingly used for allogeneic transplantation with the CD34 antigen employed in most separation techniques," hematologists in Germany explained. "However, the recently described pentaspan molecule CD133 appears to be a marker of more primitive hematopoietic progenitors."
P. Lang and colleagues at the University of Tubingen described their "experience with a new CD133-based selection method in 10 pediatric patients with matched unrelated (n=2) or mismatched-related donors (n=8)."
"These patients received a...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2004-02-05)
More Articles from Blood Weekly
- Aplastic Anemia
Th1 polarization underlies hematopoietic dysfunction in AAA patients - Cancer Therapy
Enrollment complete for phase II clinical study in non-Hodgkin lymphoma - Cancer Therapy
FLAG±Ida suitable for induction chemo in high-risk leukemia, MDS patients - Cancer Therapy
Granulocyte colony-stimulating factor reduces complications in elderly patients - Creutzfeldt Jakob Disease
Action needed to prevent spread of vCJD via blood - Environmental Health
Methemoglobin levels correlate with environmental exposures in pregnant women - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
